Acute cardiac care & resuscitation

Early Implementation of Guideline-Directed Medical Therapy and Outcomes in Cardiogenic Shock Supported by Micro-Axial Flow Pumps

Eur J Heart FailPublished multicenter prospective registry

Authors' conclusion

In patients with CS supported by Impella, early GDMT implementation was feasible in a substantial proportion of patients. Greater GDMT exposure at device explantation was associated with lower in-hospital mortality. Ventricular unloading may provide an opportunity to initiate outcome-modifying therapies during the acute phase of CS.

Study context

Population
Patients with cardiogenic shock (CS) treated with Impella between 2020 and 2024mean age 61 years, 20% female, 40% received concomitant ECMO (ECPella)
Participants
140 patients
Exposure
Number of heart failure therapies administered at device explantation
Outcome
In-hospital mortality
Methodological detailsconsecutive patients, multivariable logistic regression, landmark analysis, mixed-effects models
  • Consecutive patients
  • Multivariable logistic regression
  • Landmark analysis
  • Mixed-effects models

Main finding

As reported in the abstract

In-hospital mortality
per additional GDMT therapyEstimate (95% CI)P value
Greater GDMT exposure independently associated with lower mortality; multivariable logistic regression
OR 0.28(0.14–0.58)
P < 0.001
Landmark analysis excluding patients dying within 5 days
adjusted OR 0.31(0.16–0.66)
P < 0.001
After excluding patients with cardiac arrest
adjusted OR 0.48(0.23–0.88)
P = 0.002

Per additional GDMT therapy, as printed

In-hospital mortality (overall)
38%

Observational data: associations, not effects.

Further findings

Guideline-directed medical therapy (GDMT) at explantation

Received at least one GDMT agent
43%

GDMT intensity and survival

A graded relationship between GDMT intensity and survival was observed

Center-level variability

Intraclass correlation coefficient
0.02

Original publication

Early Implementation of Guideline-Directed Medical Therapy and Outcomes in Cardiogenic Shock Supported by Micro-Axial Flow Pumps. Eur J Heart Fail. Published 17 November 2026. doi:10.1093/ejhf/xuag338

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.